AJCC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

First published on February 20, 2009, doi:10.4037/ajcc2009467

American Journal of Critical Care 2010;19:16.

Copyright © 2009 by the American Association of Critical-Care Nurses.
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ajcc2009467v1
19/1/16    most recent
Right arrow Respond to This Article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larson, E. L.
Right arrow Articles by Behta, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larson, E. L.
Right arrow Articles by Behta, M.
RESEARCH-ARTICLE

Isolation Precautions for Methicillin-Resistant Staphylococcus aureus: Electronic Surveillance to Monitor Adherence

By Elaine L. Larson, RN, PhD, CIC, Bevin Cohen, BA, Barbara Ross, RN, BSN, CIC and Maryam Behta, PharmD. From Elaine L. Larson is associate dean for research and professor of therapeutic and pharmaceutical research in the School of Nursing and professor of epidemiology in the Mailman School of Public Health at Columbia University, New York, New York. Bevin Cohen is a project manager at the Center for Interdisciplinary Research to Prevent Antimicrobial Resistance at Columbia University. Barbara Ross is a nurse epidemiologist at New York-Presbyterian Hospital System, New York, New York. Maryam Behta is director of quality research and technology utilization for the New York-Presbyterian Hospital System

Corresponding author: Elaine L. Larson, RN, PhD, FAAN, CIC, 630 W 168th St, New York, NY 10032 (e-mail:Ell23{at}columbia.edu).

Abstract

The Centers for Disease Control and Prevention recently updated guidelines for isolation precautions and added specific recommendations for the management of multidrug-resistant organisms. However, the extent to which these recommendations are followed is unknown. Although the recommendations are based on studies with high internal validity, the effectiveness of these interventions in clinical practice also is unknown. Evidence of the effectiveness of isolation precautions for preventing transmission of infections caused by multidrug-resistant organisms in acute care settings, with methicillin-resistant Staphylococcus aureus as an example, was reviewed. Despite a lack of experimental data, numerous descriptive and correlational studies and a sound theoretical rationale strongly suggest that barrier precautions play an important role in the prevention of transmission of infections due to multidrug-resistant organisms. Two major problems, however, still exist. First, staff members’ adherence to national recommendations on isolation precautions, although insufficiently described, appears to be inadequate. Second, efficient, reproducible methods for ongoing surveillance of practices such as isolation precautions are not readily available. Automated surveillance systems that provide support for making decisions are promising for this purpose, are likely to result in cost savings, and therefore warrant more widespread development, testing, and implementation.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by the American Association of Critical-Care Nurses.